BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

Go back to BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
OPKO HEALTH, Inc. (NASDAQ: OPK) Delayed: 1.46 +0.03 (2.10%)
Previous Close $1.43    52 Week High $11.85 
Open $1.42    52 Week Low $7.12 
Day High $1.49    P/E N/A 
Day Low $1.41    EPS $-0.30 
Volume 2,843,030